Wakayama Rosai Hospital
In research, Wakayama Rosai Hospital stands highest in Medicine (#16,244 of 17,978 worldwide) and Health Sciences (#19,151 of 20,462 worldwide), over all time.
- World rank, all time
- #39,832 of 42,892
- Rank in Japan
- #1,866 of 2,112
- Research works
- 265 ▼ 35% vs 2013–17
- Citations
- 2.3k 8.7 per fractional work
- Top-10% rate
- 7.2% record average 16.5%
- Open access
- 51% world 28%
What is Wakayama Rosai Hospital known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #16,244 of 17,978 | 7.5% | 227 | |
| Health SciencesDomain | #19,151 of 20,462 | 7.4% | 231 |
Each strip is that field’s whole ranked pool, with the notch where Wakayama Rosai Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.7×. Every wedge is a field page.
Who are the top researchers at Wakayama Rosai Hospital?
Ranked on the composite score, Tomoaki Terada, M Katsumi and Yasuhito Kobayashi lead among researchers whose main affiliation is Wakayama Rosai Hospital.
- 1 Tomoaki Terada Japan · #819,988 worldwide 33 citations · 45 works
- 2 M Katsumi Japan · #832,068 worldwide 5 citations · 16 works
- 3 Yasuhito Kobayashi Japan · #843,437 worldwide 30 citations · 27 works
Which keywords describe research at Wakayama Rosai Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Hepatocellular Carcinoma, Epidemiology, Immunotherapy, Metabolic Syndrome, Insulin Resistance, Chemotherapy and Treatment.
- Complications
- Quality of Life
- Genetic Mutations
- Prognostic Factors
- Gastric Cancer
- Aging
- Degenerative Disc Disease
- Tumor Microenvironment
- Spinal Fusion
- NAFLD
- Management
- Insulin Resistance
- Metabolic Syndrome
- Treatment
- Inflammation
- Epidemiology
- Hepatocellular Carcinoma
- Immunotherapy
- Chemotherapy
- Diagnosis
- Clinical Practice Guidelines
- NASH
- Prognosis
- Cancer
- Surgical Management
- Clinical Trials
- Low Back Pain
- Endovascular Treatment
- Neoadjuvant Therapy
- Survival Analysis
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 30 words, with their numbers
- Epidemiology4▲ 3.1×21 topics
- Inflammation4▲ 5.6×15 topics
- Hepatocellular Carcinoma3▲ 39×3 topics
- Treatment2▲ 6.3×12 topics
- Immunotherapy2▲ 11×8 topics
- Metabolic Syndrome2▲ 8.9×4 topics
- Chemotherapy2▲ 10×8 topics
- Insulin Resistance2▲ 16×3 topics
- Diagnosis2▲ 6.8×8 topics
- Management2▲ 7.1×5 topics
- Clinical Practice Guidelines2▲ 9.5×4 topics
- NAFLD2▲ 43×1 topic
- NASH2▲ 43×1 topic
- Spinal Fusion2▲ 54×2 topics
- Prognosis2▲ 15×5 topics
- Tumor Microenvironment2▲ 11×5 topics
- Cancer1▲ 3.2×7 topics
- Degenerative Disc Disease1▲ 47×2 topics
- Surgical Management1▲ 9.6×6 topics
- Aging1▲ 6.7×2 topics
- Clinical Trials1▲ 5.4×6 topics
- Gastric Cancer1▲ 33×3 topics
- Low Back Pain1▲ 21×2 topics
- Prognostic Factors1▲ 8.5×5 topics
- Endovascular Treatment1▲ 57×2 topics
- Genetic Mutations1▲ 7.8×5 topics
- Neoadjuvant Therapy1▲ 14×4 topics
- Quality of Life1▲ 2.2×8 topics
- Survival Analysis1▲ 12×3 topics
- Complications1▲ 6.3×5 topics
Which research topics does Wakayama Rosai Hospital publish most on?
By volume in 2022–2025: Liver Disease Diagnosis and Treatment, Spine and Intervertebral Disc Pathology, Hepatocellular Carcinoma Treatment and Prognosis and Scoliosis diagnosis and treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Liver Disease Diagnosis and Treatment Epidemiology 2 works
- 2 Spine and Intervertebral Disc Pathology Pathology and Forensic Medicine 1 works
- 3 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 1 works
- 4 Scoliosis diagnosis and treatment Surgery 1 works
- 5 Glioma Diagnosis and Treatment Genetics 1 works
- 6 Pancreatic and Hepatic Oncology Research Oncology 1 works
- 7 Nutrition and Health in Aging Physiology 1 works
- 8 Spinal Fractures and Fixation Techniques Surgery 1 works
- 9 Intracranial Aneurysms: Treatment and Complications Neurology 1 works
- 10 Gastrointestinal Tumor Research and Treatment Gastroenterology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Wakayama Rosai Hospital's research output changed?
Output in 2018–2022 was 35% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Wakayama
- Wakayama Medical University
- Wakayama University
- Japanese Red Cross Society Wakayama Medical Center
- Kinan Hospital
- Kihoku hospital
- National College of Technology, Wakayama College
- Misato Observatory
- Hidaka Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.